Showing posts with label Stroke. Show all posts
Showing posts with label Stroke. Show all posts

Wednesday, January 6, 2010

Postmenopausal women taking antidepressants may be at higher risk for stroke, death

Moral of the story: Postmenopausal women on antidepressants are 45% more likely than those not on such medication to have a stroke, and 32% more likely to die of any cause.

AMA Morning Rounds 12/15/09

Postmenopausal women taking antidepressants may be at higher risk for stroke, death.


The Los Angeles Times (12/14, Healy) "Booster Shots" blog reported that, according to a study published in the Archives of Internal Medicine, "postmenopausal women taking antidepressants are at higher risk of suffering a stroke or of dying of any cause than are those who do not take such medications." Investigators "followed 136,293 post-menopausal women, age 50 to 79, for just under six years," during which time "5,496 developed depression and were treated with antidepressant medication." Researchers found that over the course of "follow-up, the women on antidepressants were 45% more likely than those not on such medication to have a stroke, and 32% more likely to die of any cause."
        HealthDay (12/14, Edelson) reported that while the study found that "women on selective serotonin uptake inhibitors," such as "Celexa [citalopram], Paxil [paroxetine], Prozac [fluoxetine], and Zoloft [sertraline]," as well as "tricyclic antidepressants," had an increased risk for stroke and death, "the overall risk for any one woman remained very small."

Sunday, November 29, 2009

Researchers associate low levels of vitamin D with CAD, stroke, heart failure.

Moral of the story: There is a link between the chronic, prevalent low vitamin D levels in the US and all those cardiovascular problems. It may be a tough balance between skin cancer and vitamin D, but the importance of the vitamin D is becoming more clear.

Source: AMA Morning Rounds 11/17/09

Researchers associate low levels of vitamin D with CAD, stroke, heart failure.

The New York Times (11/16, Rabin) "Well" blog reported that, according to research presented Nov. 16 at the American Heart Association conference, "Americans aren't getting anywhere nearly enough of" vitamin D, "and it may be affecting their heart health." After examining data on 27,686 "healthy adults 50 and older whose vitamin D levels had been measured during routine checkups," researchers found that "those who had extremely low levels of the vitamin were almost twice as likely to have died or suffered a stroke than those with adequate amounts." In addition, they "had more coronary artery disease and were twice as likely to have developed heart failure." HealthDay (11/16, Preidt) and CNN (11/17, Mann) also cover the study.

FDA warns against concomitant use of Plavix, certain heartburn drugs.

Moral of the story: If you are taking these two drugs (blood thinners and proton-pump inhibitors for heartburn) talk to your doctor. You need to up the dosage of the blood thinner.

Source: AMA Morning Rounds 11/18/09

FDA warns against concomitant use of Plavix, certain heartburn drugs.

NBC Nightly News (11/17, story 2, 0:40, Williams) reported that "millions of Americans take" Plavix (clopidogrel) "to reduce the risk of heart attacks and strokes." But, because the blood thinner "can upset the stomach, it is often prescribed alongside drugs like Prilosec (omeprazole) and Nexium (esomeprazole)." Now, however, the FDA is warning that those popular medications can "weaken the effect of Plavix."

In fact, the "anti-clotting benefits of Plavix are cut almost in half when taken with over-the-counter or prescription Prilosec, according to a notice posted today on the Food and Drug Administration's website," Bloomberg News (11/18, Larkin) reports. Thus, the "agency ordered Paris-based Sanofi and New York-based Bristol-Myers to update the prescribing information for Plavix and study the potential for other drug interactions." Although the "Plavix prescribing information was updated in January to discourage use with Prilosec," the latest warning includes the those two PPIs and nine other "similar drugs."

However, the agency "did not have enough information to say whether other drugs in the same class as Nexium and Prilosec...also react adversely with Plavix," the Los Angeles Times (11/18, Zajac) reports. "This includes such drugs as Prevacid [lansoprazole] and Protonix [pantoprazole]."

Nevertheless, those who still "need to reduce their acid should take drugs from the H-2 blocker family, which include Johnson & Johnson's Mylanta [aluminum hydroxide/magnesium hydroxide/simethicone] and Boehringer Ingelheim's Zantac [ranitidine]," the AP (11/18, Perrone) reports. "FDA scientists say there is no evidence those drugs interfere with Plavix's blood clotting." As for the omeprazole, the FDA decided to strengthen its warning after reviewing "a 150-patient study submitted by Sanofi over the summer."

That report indicated that drugs like Nexium reduce the production of an enzyme -- CYP 2C19 -- that sets Plavix in motion, according to the Wall Street Journal (11/18, Mundy). Several other drugs, WebMD (11/17, DeNoon) reported, "also inhibit CYP 2C19, and the FDA says patients on Plavix should avoid them as" well: Tagamet (cimetidine), Luvox (fluvoxamine), Ticlid (ticlopidine), Diflucan (fluconazole), Nizoral (ketoconazole), VFEND (voriconazole), Intelence (etravirine), Felbatol (felbamate), and Prozac, Serafem, and Symbyax (fluoxetine).

HealthDay (11/17, Reinberg), Dow Jones Newswire (11/17, Favole), and CQ HealthBeat (11/18) also covered the story

High salt intake directly linked to stroke and cardiovascular disease

Moral of the story: Eat less salt. That's it. Your heart will thank you.

Source: BMJ press releases Monday 23 November to Friday 27 November 2009. Available in full at www.bmj.com

(1) High salt intake directly linked to stroke and cardiovascular disease

(Research: Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies)
http://www.bmj.com/cgi/doi/10.1136/bmj.b4336
(Editorial: The case for population-wide salt reduction gets stronge)
http://www.bmj.com/cgi/doi/10.1136/bmj.b4336

High salt intake is associated with significantly greater risk of both stroke and cardiovascular disease, concludes a study published on bmj.com today.

The link between high salt intake and high blood pressure is well established, and it has been suggested that a population-wide reduction in dietary salt intake has the potential to substantially reduce the levels of cardiovascular disease.

The World Health Organization recommended level of salt consumption is 5 g (about one teaspoon) per day at the population level, yet dietary salt intake in most Western countries is close to 10g per day (and much higher in many Eastern European countries).

Collaborative research conducted by Professor Pasquale Strazzullo at the University of Naples, Italy and Professor Francesco Cappuccio at the University of Warwick, UK analysed the results of 13 published studies involving over 170,000 people that directly assessed the relationship between levels of habitual salt intake and rates of stroke and cardiovascular disease.

Differences in study design and quality were taken into account to minimise bias.

Their analysis shows unequivocally that a difference of 5 g a day in habitual salt intake is associated with a 23% difference in the rate of stroke and a 17% difference in the rate of total cardiovascular disease.

Based on these results, the authors estimate that reducing daily salt intake by 5 g at the population level could avert one and a quarter million deaths from stroke and almost three million deaths from cardiovascular disease each year. Furthermore, because of imprecision in measurement of salt intake, these effect sizes are likely to be underestimated, say the authors.

These results support the role of a substantial population reduction in salt intake for the prevention of cardiovascular disease, they conclude.

This study is a useful and welcome addition to the medical literature, and strengthens the case for population-wide salt reduction, says Professor Lawrence Appel from Johns Hopkins University, in an accompanying editorial.

Contacts:
Research: Pasquale Strazzullo, Professor of Medicine, Department of Clinical and Experimental Medicine, "Federico II" ESH Excellence Centre of Hypertension, University of Naples Medical School, Naples, Italy
Email: strazzul@unina.it

Editorial: Lawrence Appel, Professor of Medicine (via Stephanie Desmon, Senior Media Relations Representative), Johns Hopkins University, Baltimore, MD, USA
Email: sdesmon1@jhmi.edu

Thursday, October 29, 2009

Migraine with aura doubles the risk of stroke

Moral of the story: If you have migraine headaches with aura you should reevaluate taking oral contraceptives and smoking based on stroke risk.

Source: AMA Morning Rounds 10/28/09
HealthDay (10/27, Reinberg) reported, "Women who get migraine headaches with aura should stop smoking and using birth control pills, because they may increase their risk of stroke," according to a study appearing online Oct. 27 in the British Medical Journal. Investigators "analyzed nine studies concerning the association between migraine, with and without aura, and cardiovascular disease." The study showed that "migraine alone does not appear to alter the risk for heart attack and death from cardiovascular disease."

Source: British Medical Journal press releases
(Research: Migraine and cardiovascular disease: systematic review and meta-analysis)
http://www.bmj.com/cgi/doi/10.1136/bmj.b3914
(Editorial: Migraine with aura and increased risk of ischaemic stroke)
http://www.bmj.com/cgi/doi/10.1136/bmj.b4380

Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today. Further risk factors for stroke among patients with migraine are being a woman, being young, being a smoker, and using oestrogen containing contraceptives.

The risk was highest among young women with migraine with aura who smoke and use oestrogen containing contraceptives.

Migraine is a common, chronic disorder that affects up to 20% of the population. Women are affected up to four times more often than men. Up to one third of sufferers also experience an aura prior to or during a migraine headache (often described as the perception of a strange light, an unpleasant smell or confusing thoughts or experiences).

Doctors have long suspected a connection between migraine and vascular events such as stroke. So to investigate this further, an international team of researchers analysed the results of nine studies on the association between any migraine (with and without aura) and cardiovascular disease. Differences in study design and quality were taken into account to minimise bias.

They show that migraine with aura is associated with a twofold increased risk of ischemic stroke. This risk is further increased by being female, age less than 45 years, smoking, and oestrogen containing contraceptive use.

There was no association between migraine and heart attack or death due to cardiovascular disease.

In light of these findings, the authors recommend that young women who have migraine with aura should be strongly advised to stop smoking, and methods of birth control other than oestrogen containing contraceptives should be considered. They also call for additional research to investigate the association between migraine and cardiovascular disease in more detail.

The absolute risk of stroke for most migraine patients is low, so a doubling of risk is not cause for panic, explains Elizabeth Loder from Brigham and Women's Hospital, Boston, in an accompanying editorial. However, at a population level, this risk deserves attention because the prevalence of migraine is so high.

She suggests that patients who have migraine with aura should be followed closely and treated aggressively for modifiable cardiovascular risk factors.

Contacts:
Research: Kevin Myron, Manager, Media Relations, Brigham and Women's Hospital, Office of Public Affairs, Boston, MA, USA
Email: kmyron@partners.org

Editorial: Elizabeth Loder, Chief, Division of Headache and Pain, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Email: eloder@partners.org

Wednesday, March 18, 2009

Metabolic disorders linked to cognitive decline

Moral of the story: Manage your chronic diseases! Stay on top of treatment, exercise and see your doctor. The last thing you want on top of diabetes is Alzheimer's disease.

Metabolic disorders linked to cognitive decline
March 17, 2009 Allison Gandey
Edited from Medscape Medical News—a professional news service of WebMD

New York, NY and Seattle, WA - Evidence is mounting that metabolic and neurological diseases share common risk factors, according to two studies in the March 2009 issue of the Archives of Neurology.
"Preventing heart disease, stroke, and diabetes—or making sure these conditions are well managed in patients diagnosed with them—can potentially slow the disease progression of Alzheimer's," senior author on one of the studies, Dr Yaakov Stern (Columbia University, New York), said in a news release. Stern et al, led by Dr Elizabeth Helzner (Columbia University) hypothesized that vascular factors such as heart disease, stroke, diabetes, hypertension, smoking, and blood lipid levels may predict the progression of Alzheimer's disease [1]. The group studied 156 patients followed for a mean of 3.5 years. Participants were from the Washington Heights and Inwood Columbia Aging Project, a multiethnic, community-based, prospective study of aging in northern Manhattan.
Researchers found that patients with a history of diabetes and elevated levels of cholesterol, especially LDL cholesterol, had faster cognitive decline. In fact, each 10-U increase in cholesterol and LDL cholesterol was associated with a 0.10-standard-deviation decrease in cognitive score per year of follow-up (p<0.001 for total cholesterol; p=0.001 for LDL cholesterol).
Investigators found that a history of heart disease and stroke were associated with cognitive decline only in carriers of the APOE e4 allele.
"These findings indicate that controlling vascular conditions may be one way to delay the course of Alzheimer's, which would be a major development in the treatment of this devastating disease," Stern said.Fluctuations in weight may boost dementia risk
In the second study published in the same issue of the Archives of Neurology, investigators show that obese middle-aged adults and underweight elderly people have an increased dementia risk [2].
Using data from the Cardiovascular Health Study, researchers studied the body-mass index (BMI) of participants at mid- and late life. Patients were from a community-dwelling sample at four US sites.
Investigators included 2798 people. Of these, 480 had incident dementia, 245 had Alzheimer's disease, and 213 had vascular dementia.
They found that middle-aged patients who were obese had an increased risk for dementia (BMI >30 vs normal-weight BMI 20 to 25), adjusted for demographics (hazard ratio 1.39; 95% CI 1.03-1.87), although this observation was weakened after adjustment for cardiovascular risk factors (hazard ratio 1.36; 95% CI 0.94-1.95).
These results help explain the 'obesity paradox.'
But the risk estimates were reversed in assessments of late-life BMI. Underweight people, those with a BMI of less than 20, had an increased risk for dementia (hazard ratio 1.62; 95% CI 1.02-2.64). Surprisingly, being overweight later in life was not associated with an increased risk (hazard ratio 0.92; 95% CI 0.72-1.18), and being obese reduced the risk for dementia (hazard ratio 0.63; 95% CI 0.44-0.91).
"These results help explain the 'obesity paradox,' " the researchers, led by Dr Annette Fitzpatrick (University of Washington, Seattle), write. "Differences in dementia risk across time are consistent with physical changes in the trajectory toward disability."
These findings suggest that the predictive ability of BMI changes across time, they note
"Weight loss occurs with comorbidities at older ages and is often reflective of poor health," write Fitzpatrick and her team. "Weight loss, along with psychological, behavioral, and mobility problems, is one of the principal manifestations of Alzheimer's disease. Weight loss may predate dementia onset by as much as 10 years."
The researchers conclude: "These results reinforce the necessity of monitoring weight loss closely in older adults."
The complete contents of Medscape Medical News, a professional news service of WebMD, can be found at www.medscape.com, a website for medical professionals.
Sources
Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 2009; 66:343-348.
Fitzpatrick AL, Kuller LH, Lopez OL, Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66:336-342.
Related links
Adherence to Mediterranean diet reduces risk of major chronic diseases [Prevention > Prevention; Sep 12, 2008]
Heart disease linked to poor cognitive function in middle age [Brain/Kidney/Peripheral > Brain/Kidney/Peripheral; Jul 23, 2008]
Low HDL-C associated with poor memory [HeartWire > Brain/Kidney/Peripheral; Jun 30, 2008]
High cholesterol linked to increased AD risk [HeartWire > Medscape Medical News; Nov 06, 2006]
Low cholesterol linked to reduced cognitive function [HeartWire > News; Mar 23, 2005]
Lipid metabolism abnormalities observed in brain aging and Alzheimer's disease [HeartWire > News; Feb 15, 2004]

Friday, February 27, 2009

Green and Black Tea Consumption and Risk of Stroke. A Meta-Analysis

Moral of the story: Drinking black and green tea can help prevent a stroke. A meta-analysis is an analysis of all the literature on a single topic. This study found that taken all together, studies suggest that 3 cups of tea may be effective.

Green and Black Tea Consumption and Risk of Stroke. A Meta-Analysis

Lenore Arab PhD*;
Weiqing Liu MS; and David Elashoff PhD

From UCLA's School of Medicine, Los Angeles, Calif.

* To whom correspondence should be addressed. E-mail: Larab@ucla.edu.

Background and Purpose—Experimental models of stroke provide consistent evidence of smaller stroke volumes in animals ingesting tea components or tea extracts. To assess whether a similar association of black or green tea consumption with reduced risk is evident in human populations, we sought to identify and summarize all human clinical and observational data on tea and stroke.

Methods—We searched PubMed and Web of Science for all studies on stroke and tea consumption in humans with original data, including estimation or measurement of tea consumption and outcomes of fatal or nonfatal stroke. Data from 9 studies involving 4378 strokes among 194 965 individuals were pooled. The main outcome was the occurrence of fatal or nonfatal stroke. We tested for heterogeneity and calculated the summary effect estimate associated with consumption of ≥3 cups of tea (green or black) per day using random-effects and fixed-effects models for the homogeneous studies. Publication bias was also evaluated.

Results—Regardless of their country of origin, individuals consuming ≥3 cups of tea per day had a 21% lower risk of stroke than those consuming <1> 0.85). The proportion of heterogeneity not explained by chance alone was 23.8%.

Conclusions—Although a randomized clinical trial would be necessary to confirm the effect, this meta-analysis suggests that daily consumption of either green or black tea equaling 3 cups per day could prevent the onset of ischemic stroke.


Key words: black tea • Camelia sinensis • green tea • ischemic stroke • theophylline